FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021673229> ?p ?o ?g. }

• W2021673229 endingPage "543" @default.
• W2021673229 startingPage "537" @default.
• W2021673229 abstract "Aims To determine the effects of pioglitazone (30 mg once daily for 16 weeks) on insulin sensitivity, insulin-mediated vasodilation, vascular inflammatory markers, fat distribution and lipids in Asian Indians and Caucasians of European ancestry. Methods Cross-sectional study. Eighteen non-diabetic Asian Indians and 17 Caucasians of comparable age (34 ± 3 vs. 36 ± 3 years) and body mass index (26.0 ± 1.2 vs. 24.7 ± 1.0 kg/m2) had measurements of insulin sensitivity (M, insulin clamp at 6 pmol/kg per min), abdominal fat (computed tomographic scan at L4-L5), endothelial-dependent (reactive hyperaemia, RH) and -independent (0.4 mg sublingual nitroglycerin, TNG) vasodilation using brachial artery ultrasound before and after the 2-h clamp at baseline and after pioglitazone therapy. Results Asian Indians were insulin resistant compared with Causasians during the baseline clamp (M = 25.6 ± 1.7 vs. 41.1 ± 2.2 µmol/kg per min, P < 0.0001) and improved significantly after pioglitazone (to 33.9 ± 1.7 µmol/kg per min, P < 0.001). Vasodilatory responses to RH and TNG were similar in Asian Indians and Caucasians at baseline and did not change. Insulin-mediated vasodilation improved after pioglitazone in Asian Indians, but not in Caucasians, and correlated with the change in insulin sensitivity (r = 0.52, P = 0.03). C-reactive protein (CRP) was higher in Asian Indians vs. Caucasians (1.6 ± 0.4 vs. 0.9 ± 0.2 mg/l) and was negatively correlated with insulin sensitivity (r = −0.53, P = 0.02). In the Asian Indian group, CRP and plasminogen activator inhibitor-1 decreased and adiponectin increased after pioglitazone, but there were no significant changes in total or visceral fat. Conclusions These results demonstrate that insulin-resistant Asian Indians respond favourably to an insulin sensitizer with improvements in insulin sensitivity, cardiovascular and inflammatory risk markers, and vascular responses to insulin. These agents may have a role in decreasing the risk of diabetes and cardiovascular disease in this high-risk population." @default.
• W2021673229 created "2016-06-24" @default.
• W2021673229 creator A5009169643 @default.
• W2021673229 creator A5014878886 @default.
• W2021673229 creator A5034452502 @default.
• W2021673229 creator A5038247520 @default.
• W2021673229 creator A5083651022 @default.
• W2021673229 date "2006-05-01" @default.
• W2021673229 modified "2023-10-14" @default.
• W2021673229 title "Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians" @default.
• W2021673229 cites W1655888365 @default.
• W2021673229 cites W192171695 @default.
• W2021673229 cites W1968590931 @default.
• W2021673229 cites W1976766119 @default.
• W2021673229 cites W1982811953 @default.
• W2021673229 cites W1991403690 @default.
• W2021673229 cites W1991844886 @default.
• W2021673229 cites W1993387626 @default.
• W2021673229 cites W1997021848 @default.
• W2021673229 cites W2009039817 @default.
• W2021673229 cites W2018135697 @default.
• W2021673229 cites W2018418569 @default.
• W2021673229 cites W2020598725 @default.
• W2021673229 cites W2023323317 @default.
• W2021673229 cites W2025351604 @default.
• W2021673229 cites W2040855107 @default.
• W2021673229 cites W2046244117 @default.
• W2021673229 cites W2062637684 @default.
• W2021673229 cites W2063506869 @default.
• W2021673229 cites W2065501573 @default.
• W2021673229 cites W2066062695 @default.
• W2021673229 cites W2092508849 @default.
• W2021673229 cites W2095369117 @default.
• W2021673229 cites W2107298817 @default.
• W2021673229 cites W2128712342 @default.
• W2021673229 cites W2132594773 @default.
• W2021673229 cites W2132823438 @default.
• W2021673229 cites W2140603676 @default.
• W2021673229 cites W2161646349 @default.
• W2021673229 cites W2168553115 @default.
• W2021673229 cites W2324841714 @default.
• W2021673229 cites W4236535242 @default.
• W2021673229 cites W4243775069 @default.
• W2021673229 cites W4255297658 @default.
• W2021673229 cites W49602467 @default.
• W2021673229 doi "https://doi.org/10.1111/j.1464-5491.2006.01843.x" @default.
• W2021673229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16681563" @default.
• W2021673229 hasPublicationYear "2006" @default.
• W2021673229 type Work @default.
• W2021673229 sameAs 2021673229 @default.
• W2021673229 citedByCount "21" @default.
• W2021673229 countsByYear W20216732292013 @default.
• W2021673229 countsByYear W20216732292014 @default.
• W2021673229 countsByYear W20216732292015 @default.
• W2021673229 countsByYear W20216732292016 @default.
• W2021673229 countsByYear W20216732292018 @default.
• W2021673229 countsByYear W20216732292022 @default.
• W2021673229 countsByYear W20216732292023 @default.
• W2021673229 crossrefType "journal-article" @default.
• W2021673229 hasAuthorship W2021673229A5009169643 @default.
• W2021673229 hasAuthorship W2021673229A5014878886 @default.
• W2021673229 hasAuthorship W2021673229A5034452502 @default.
• W2021673229 hasAuthorship W2021673229A5038247520 @default.
• W2021673229 hasAuthorship W2021673229A5083651022 @default.
• W2021673229 hasConcept C120770815 @default.
• W2021673229 hasConcept C126322002 @default.
• W2021673229 hasConcept C134018914 @default.
• W2021673229 hasConcept C158846371 @default.
• W2021673229 hasConcept C2777180221 @default.
• W2021673229 hasConcept C2777391703 @default.
• W2021673229 hasConcept C2777604165 @default.
• W2021673229 hasConcept C2777691872 @default.
• W2021673229 hasConcept C2778384471 @default.
• W2021673229 hasConcept C2778808658 @default.
• W2021673229 hasConcept C2779306644 @default.
• W2021673229 hasConcept C3017594256 @default.
• W2021673229 hasConcept C555293320 @default.
• W2021673229 hasConcept C71924100 @default.
• W2021673229 hasConcept C84393581 @default.
• W2021673229 hasConceptScore W2021673229C120770815 @default.
• W2021673229 hasConceptScore W2021673229C126322002 @default.
• W2021673229 hasConceptScore W2021673229C134018914 @default.
• W2021673229 hasConceptScore W2021673229C158846371 @default.
• W2021673229 hasConceptScore W2021673229C2777180221 @default.
• W2021673229 hasConceptScore W2021673229C2777391703 @default.
• W2021673229 hasConceptScore W2021673229C2777604165 @default.
• W2021673229 hasConceptScore W2021673229C2777691872 @default.
• W2021673229 hasConceptScore W2021673229C2778384471 @default.
• W2021673229 hasConceptScore W2021673229C2778808658 @default.
• W2021673229 hasConceptScore W2021673229C2779306644 @default.
• W2021673229 hasConceptScore W2021673229C3017594256 @default.
• W2021673229 hasConceptScore W2021673229C555293320 @default.
• W2021673229 hasConceptScore W2021673229C71924100 @default.
• W2021673229 hasConceptScore W2021673229C84393581 @default.
• W2021673229 hasIssue "5" @default.
• W2021673229 hasLocation W20216732291 @default.
• W2021673229 hasLocation W20216732292 @default.
• W2021673229 hasOpenAccess W2021673229 @default.

• next